Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 12, 2001

View Archived Issues

Licensing opportunity from NIH: novel posttranscriptional regulatory elements

Licensing opportunity from NIH: acridine derivative for overcoming MDR

Gilead reports product and pipeline highlights for 2000

Nicotine replacement therapy business of Aventis acquired by Pharmacia

Alza acquires Flexeril product and trademark from Merck & Co.

ARGENT technology demonstrates potential in prostate cancer

Medarex and Seattle Genetics to jointly develop human antibody therapeutics

NCX-530 is less toxic than indomethacin to the intestine according to rat studies

Highly potent HIV protease inhibitors from Tibotec may prevent class-wide crossresistance

Magainin and Ludwig Institute further their gene/protein-based alliance

Inhibitor of HIV-1 Rev function acts on receptor-mediated export

Kinetic and clinical data presented in Chicago support further development of DAPD

Approvable letter issued by FDA for GlaxoSmithKline's Avandia in combination with insulin

LDP-02 enters phase II in Canada for ulcerative colitis

Next-generation NNRTI advances to clinical testing in HIV-infected subjects

Second-generation HIV protease inhibitors retain activity against highly resistant strains

KS Biomedix's KSB-301 enters phase II for osteoarthritis

Promising preclinical data reported for Isotechnika immunosuppressant in type 1 diabetes

First oral chemotherapy for treatment of metastatic colorectal cancer approved in Europe

Antisense modulators of integrin beta3 expression

Isis designs antisense oligonucleotides that modulate the expression of G-proteins

Cationic peptides with antibacterial activity described by Canadian university

Novel series for diabetes and related disorders emerges from Tularik-JT collaboration

Panacos and collaborators discuss preclinical profile of anti-HIV candidate

Aventis presents new antibacterial agents derived from moenomycin A

European patent issued to Pfizer for new opioid receptor antagonists

Heterocyclic inhibitors of tyrosine kinase-mediated signal transduction

Kissei and Purdue Pharma terminate licensing agreement for mitiglinide

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...